In the study of "Combined effects of MDM2 SNP309 and TP53 R72P polymorphisms, and soy isoflavones on breast cancer risk among Chinese women in Singapore" by Koh WP, Van Den Berg D, Jin A, Wang R, Yuan JM, Yu MC., posted in US National Library of Medicine National Institutes of Health, researchers found that support experimental data implicating combined effects of MDM2 protein and the p53-mediated pathway in breast carcinogenesis, and suggest that soy isoflavones may exert protective effect via down-regulation of the MDM2 protein.
Google Ads
Natural Medicine for Fatty Liver And Obesity Reversal
Tuesday, October 25, 2011
Soy isoflavones and Prevention of Breast Cancer
Posted by Chantel M. Contributed by US National Library of Medicine National Institutes of Health
In the study of "Combined effects of MDM2 SNP309 and TP53 R72P polymorphisms, and soy isoflavones on breast cancer risk among Chinese women in Singapore" by Koh WP, Van Den Berg D, Jin A, Wang R, Yuan JM, Yu MC., posted in US National Library of Medicine National Institutes of Health, researchers found that support experimental data implicating combined effects of MDM2 protein and the p53-mediated pathway in breast carcinogenesis, and suggest that soy isoflavones may exert protective effect via down-regulation of the MDM2 protein.
In the study of "Combined effects of MDM2 SNP309 and TP53 R72P polymorphisms, and soy isoflavones on breast cancer risk among Chinese women in Singapore" by Koh WP, Van Den Berg D, Jin A, Wang R, Yuan JM, Yu MC., posted in US National Library of Medicine National Institutes of Health, researchers found that support experimental data implicating combined effects of MDM2 protein and the p53-mediated pathway in breast carcinogenesis, and suggest that soy isoflavones may exert protective effect via down-regulation of the MDM2 protein.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment